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Summary: The validity of monoamine oxidase (EC 1.4.3.4) activity in serüm for the diagnosis of fibroproliferative
liver disorders was assessed by measuring the specificity, sensitivity and positive and negative predictive values of the
enzyme. Enzyme activity was measured in sera of 567 patients including those with biochemically and/or histologi-
cally verified non-fibrotic liver diseases (n = 64), liver fibrosis (n = 45), and liver cirrhosis (n = 51).
The fraction of liver cirrhotic subjects with pathologically elevated monoamine oxidase activity (> 630 U/l) was
0.61, whereas only 0.16 of the cases with liver fibrosis and 0.11 of those with non-fibrotic liver diseases had ab-
normally high enzyme activities. Among the various categories of diseases tested, significantly increased enzyme
activities were confined to liver cirrhosis and chronic active hepatitis. For liver cirrhosis, sensitivities and specificities
were calculated äs functions of various cut-off (critical) values of monoamine oxidase activity in serum, and with
respect to a reference population of healthy men and non-cirrhotic subjects. The predictive value of the positive test
result (enzyme activity higher than 720 U/l) at a prevalence of liver cirrhosis of maximum 0.033 (estimated incidence
of chronic liver diseases in West-Germany) is 0.68 if tested against healthy persons and less than 0.30 if tested against
patients with non-liver cirrhotic diseases. It is concluded that monoamine oxidase is probably not helpful in the early
diagnosis of fibroproliferative liver dysfuiictions but may provide a parameter of complications of cirrhosis, e.g.
portal-systemic collateral circulation (portal hypertension).
Die Zuverlässigkeit der Monoamin-Oxidase im Serum für die Diagnose der Lebercirrhose:
Bestimmung der Vörhersagewerte, Sensitivitäten und Spezifitäten
Zusammenfassung: Die Kriterien der diagnostischen Zuverlässigkeit wie Spezifität, Sensitivität sowie positive und
negative prädiktive Werte der Monoamin-Oxidase (EC 1.4.3.4) Aktivität im Serum für fibroproliferative Lebererkran-
kungen wurden berechnet. Enzymäktivitäten wurden bestimmt in den Sera von 567 Patienten einschließlich derer
mit biochemisch und/oder histologisch verifizierten nicht-fibrotischen Lebererkrankungen (n = 64), Leberfibrose
(n = 45) und Lebercirrhose (n = 51). Es wird festgestellt, daß ein Anteil von 0,61 der cirrhotischen Patienten patho-
logisch erhöhte Monoamin-Oxidase Aktivitäten (> 630 U/l) besitzt, wohingegen nur 0,16 der Fälle mit Leberfibrose
und 0,11 derjenigen mit nicht-fibrotischen Lebererkrankungen abnormal hohe Enzymaktivitäten aufweisen. Unter
den verschiedenen, getesteten Krankheitskategorien sind deutlich erhöhte Enzymaktivitäten auf die Fälle mit Leber-
cirrhose und chronisch aktiver Hepatitis beschränkt. Für Lebercirrhpsen wurden Sensitivitäten und Spezifitäten be-
rechnet in Abhängigkeit verschiedener kritischer Werte der Monoamin-Oxidase Aktivität im Serum und in Bezug auf
Referenzpopulationen von gesunden Erwachsenen sowie nicht-cirrhotischen Patienten. Der Vorhersagewert des posi-
tiven Testergebnisses (Enzymaktivität höher als 720 U/l) bei einer Prävalenz der Lebercirrhosen von maximal 0,033
(geschätzte Inzidenz der chronischen Lebererkrankungen in der Bundesrepublik Deutschland) beträgt 0,68, wenn
berechnet in Bezug auf gesunde Personen und weniger als 0,30, wenn berechnet in Bezug auf nicht-lebercirrhotische
Patienten. Aus den Ergebnissen ist zu schließen, daß die Monoamin-Oxidase wahrscheinlich nicht hilfreich ist in
der Frühdiagnose fibroproliferativer Lebererkrankungen, sondern möglicherweise ein Parameter für Komplikationen
der Lebercirrhose, z.B. der porto-systemischen Kollateralzirkulation (portale Hypertension) darstellt.
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Introduction
In the past 20 years incidence and mortality of liver
cirrhosis have nearly doubled and still continue to in-
crease in most countries mainly due to an increase in the
number of etiologic factors such äs alcohol consumption,
infections with hepatotropic viruses and chronic intake ,
of facultative hepatotoxic drugs (1-4). It is estimated j
that currently more than 300000 patients per year die
because of the direct or indirect consequences of liver
cirrhosis (5). Both the large number of patients having
chronic liver damage (roughly two millions in West-
Germany, (6)) and the chronicity of the disease result in
a considerable social and economic significance of this
group of diseases (7—9).
In the sequence of pathobiochemical alterations in long-
term damaged liver parenchyma cirrhosis represents the
final, mostly irreversible stage (10—12). Thus, any success-
ful handling of the disease is confined to early phases, in
which it may be possible to stop excessive intercellular
connective tissue.formation. This, however, necessitates
the availability of valid, organ- and disease-specific, sensi-
tive diagnostic parameters of active fibroplasia. Specimen
collection must also be convenient for the patient so that
it can be performed frequently during the follow-up of
chronic liver damage. As reviewed previously (12,13)
the measurement of monoamine oxidase (EC 1.4.3.4) in
serum has been suggested äs a valuable diagnostic proce-
dure for liver fibrosis and cirrhosis because elevated
activities were found to be frequently associated with
this disease. However, up to now there have been no
quantitative assessments of the diagnostic validity of
serum monoamine oxidase for liver cirrhosis, i.e. the
calculation of predictive value (14), and diagnostic sen-
sitivity and specificity (15) are lacking. Using the
modified (16) colorimetric assay for monoamine oxidase
in serum (17) we determined the activity of this enzyme
in sera of patients with histologically verified liver
diseases and non-liver diseases in order to calculate the
criteria of diagnostic validity mentioned above.
Materials and Methods
Materials
The commercial sources of the materials used for determination
of the activity of monoamine oxidase in serum and of the
quality control sera were äs reported previously (16).
Specimen collection
During a period of 8 months sera of 567 patients and 243
apparently healthy persons (16) were analysed for activity of
monoamine oxidase. The patients with no cünical Symptoms
and n o laboratory test results typical for liver diseases, were
assigned to one of the categories listed in figure 1. On the basis
of pathologic liver f unction tests and the results of histologic
examination of liver biopsy specimens patients with liver diseases
were subdivided into those with acute viral hepatitis B, chronic
persistent hepatitis, chronic active hepatitis, liver fibrosis and
liver cirrhosis, respectively. With the exception of most of the
patients suffering from chronic liver diseases, the analysed sera
were those received routinely at the central laboratory of the
department of clinical chemistry of the Technical University,
Aachen. Sera of patients having chronic liver diseases (n = 105)
were obtained mainly from the Stoffwechselklinik der LVA,
Bad Mergentheim. Since the activity of monoamine oxidase in
serum decreases rather rapidly during storage at room tempera-
ture (16) enzyme activity was assayed either immediately after
blood collection or, äs in the case of sera obtäjned from the
Stoffwechselklinik, catalytic function was preserved by deep-
freezing the specimens for 5 to 8 days.
Venous blood was taken in the morning, allowed to clot for
about l h at room tempef ature and serum was prepared by
centrifugatiOn using Sure-Sep II serum-plasrna Separator.
Assay of monoamine oxidase (EC 1.4.3.4)
In principle the activity of the enzyme was determined aecording
to the colorimetric procedure of et al. (17) including slight
modifications äs described recently (16). The criteria of analyti-
cal validity of the assay procedure have been reported in a
previous communication (16). Inter assay precision was deter-
mined with Validate A (Gödecke) and Örtho Normal (Qrtho
Diagnostics) äs control sera and foünd to have a CV between 10
and 14%.
Statistical evaluation
In calculating the criteria of tne diagnostic validity öf serum
monoamine oxidase for liver cirrhosis, against the respective
reference population of healthy persons or non-cirrhotic patients,
the following definitions (15) were used:
a) diagnostic sensitivity
Proportion of pathologic monoamine oxidase activities within
the liver-cirrhotic population
b) diagnostic specificity
Proportion of normal monoamine oxidase activities within the
reference population
c) predictive value of pathologic monoamine oxjdase activity
(positive test result)
Probability of the presence of liver cirrhosis if the test result is
positive; with respect to the reference population.
d) predictive value of normal monoamine oxidase activity
(negative test result) ' s-
Probability of the absence of cirrhosis if the test result is nega-
tive; with respect to the reference population.
The predictive values are functions of the prevalence defined äs
prevalence cirrhosis = Proportion of cirrhotic cases within the
total population under consideration.
The estimates of the criteria defined above were calculated by
the relative frequencies of positive and negative test results in
the given samples for värious cut-off (criticäl) values (upper
"normal" limit) of monoamine oxidase activity. Enzyme activ-
ities above these limits were regarded äs pathologic.
Results
Monoamine oxidase activity in sera of patients
with värious liver and non-liver disorders
In a previous study the reference ranges for the aotivity
of serum monoamine oxidase were deteimined and
found to have an upper limit (+ 2s value) of 630 U/l
(16). An overall iinpression of the distribution of mono-
amine oxidase activities in sera of patients with a väriety
of non-liver and liver diseases is given by figüre 1. Except
for diabetes mellitus monoamine oxidase activity is
quite independent of the type of disease, i.e. the ineän
activity in the categories tested was iflAhe ränge between
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Fig. 1. Frequency distribution of monoamine oxidase activities measured in the sera of patients with neoplastic (n = 68, tumours),
gastro-intestinal (n = 15, intestinal), cardio-vascular (n = 63, card.-vascular), renal (n = 40), dermatological (n = 35, skin) and
neurological (n = 45, neurol.) disorders and in patients with diabetes mellitus (n = 19) and various entities of diseases (n = 63,
unspecified); chronic persistent Hepatitis (n = 6), chronic active Hepatitis (n = 4), cholecystitis (n = 18), acute Hepatitis
(n = 26), liver cirrhosis (n = 51), liver fibrosis (n = 45);«- indicates the mean activity in each category. v the upper l s limit,
A the lower l s limit.
300 and 400 U/l. Diabetic patients have a slightly ele-
vated mean enzyme activity of 450 U/l. Among persons
suffering from acute and chronic liver diseases only
those with cirrhosis or chronic active hepatitis have
elevated enzyme activities. The mean activity in sera of
patients with cirrhosis and active hepatitis was found to
be 770 U/l; extreme values were above 1100 U/l (fig. 1).
In accordance with previous repqrts (18—21) acute viral
hepatitis is not associated with pathologically high mono-
amine oxidase activities (> 630 U/l) in sera. Thus, signif-
icently increased enzyme activities are confined to
patients with liver cirrhosis and chronic active hepatitis,
but the number of tested patients with the latter disease
is rather low. This is confifmed by the data showing the
frequency distribution of serum monoamine oxidase
activities in cirrhotic subjects in comparison to those
with liver fibrosis, non-fibrotic liver diseases and non-
liver diseases (tab. 1). Whereas the fraction of liver
cirrhotic subjects with pathologically elevated serum
monoamine oxidase activity (> 630 U/l) is 0.61, only
0.16 of the cases with liver fibrosis and 0.11 ofthose
with non-fibrotic liver diseases are associated with
elevated enzyme activities. Among the persons with
non-liver diseases 0.07 have monoamine oxidase activ-
ities higher than 630 U/l. It is noteworthy that mono-
amine oxidase activities in sera of cirrhotic subjects
seem to have a bimodal frequency distribution (see
also fig. 1).
Tab. 1. Ftequency distribution of monoamine oxidase activities in sera of Healthy persons and patients with liver fibrosis, cirrhosis,
non-fibrotic liver diseases* and non-liver diseases, respectively.
Category
Healthy persons
Non-liver diseases
Non-fibrotic liver diseases
Liver fibrosis
Liver cirrhosis
Monoamine oxidase, cataiytic activity (U/l)
0- 511- 541- 571- 601-
(n = 243)
(n = 407)
(n= 64)
(n= 45)
(n= 51)
510
209
330
51
31
14
540
17
14
2
1
3
570
5
20
0
2
3
600
2
9
1
3
0
630
3
6
3
1
0
631-
660
3
9
1
2
3
661-
690
1
3
0
2
0
691-
720
1
6
1
0
1
>721
2
10
5
3
27
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Sensitivity and specificity of monoamine oxidase
for liver cirrhosis
Since liver cirrhosis was the only disease-category havilig
an abnormal distribution of monoamine oxidase activity
in serum, its sensitivity and specificity for cirrhosis
were estimated äs function of various cut-off values
(upper "normal" limit of monoamine oxidase activity)
(fig. 2). It is evident that the specificity of monoamine
oxidase for the detection of liver cirrhosis related to a
population of healthy persons (fig. 2a) and to non-liver
cirrhotic patients (fig. 2b), respectively, improves with
increasing cut-off values. Of course, this is accompanied
by a loss of sensitivity (fig. 2). The specificity of mono-
amine oxidase for cirrhosis is slightly higher with respect
to a reference population of healthy men than with
respect to non-cirrhotic patients suffering from a variety
of other liver and non-liver diseases (fig. 2a, b).
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Fig. 2. Estimated sensitivity (o) and specificity (·) of mono-
amine oxidase for liver cirrhosis äs function of various
cut-off (critical) values of activity (above which the test
result is regarded äs pathologic). In figure 2a the criteria
are tested against a population of healthy persons, in
figure 2b against patients suffering from a variety of
liver and non-liver diseases.
The predictive values of the positive test äs a function of
cut-off values at a prevalence of cirrhosis of 0.033 (esti-
mated prevalence of chronic liver diseases in West-Ger-
many) (6) with respect to healthy persons (fig. 2a, *—»>)
and 0.09 (fraction of cirrhotic patients in our test sample)
with respect to non-cirrhotic patients (fig. 2b, *—» ) are
illustrated.
The predictive value in figure 2b would further decrease
if based on a prevalence of 0.033 äs in fig. 2a (compare
fig. 4).
Predictive values o f monoamine oxidase for liver
cirrhosis
The estimated predictive values of the positive (abnormal
high monoamine oxidase activity) and negative (nofrnal
monoamine oxidase activity) test resüli, äs a function of
the prevalence of ciirhosis, are illustrated in figures 3
and 4. As shown, the predictive values of monoamine
oxidase are better at a cut-off value of 720 U/l than at
630 Ü/l (fig. 2) and against a reference population of
healthy persons (fig. 3) than against diseased persons
(fig. 4). If we assume a prevalence of chronic liver
diseases including liver cirrhosis of 0:033 in West-Ger-
many (6) monoamine oxidase activities above 720 U/l
would have a predictive value of 0.68 if tested against
healthy persons and of less than 0.30 if tested against
patients suffering from diseases öther than liver cirrhosis.
0.2 OA 0,6 -, 0.8
Prevolence of cirrhösis
Fig. 3. Estimated predictive values of normal (negative test
resulO ) and pathologically elevated (positive test
result, /^) monoamine oxidase activities äs a function of
disease prevalence with respect to a healthy population.
They were calculated for a cut-off value of enzyme
activity of 630 U/l (—) and 720 U/l (—-), respec-
tively.
Discussion
Previous studies have established elevated activities of
serum monoamine oxidase under a variety of pathologi-
cal conditions, in particular in progressive liver fibrosis
(17—24). The latter observation pointed to a possible
diagnostic significance of this parameter for fibroprolifera-
tive liver disorders although a functional role of this
enzyme in hepatic connective tissue metabolismi, e.g. in
collagen and/or elastin cross-linking isaot firmly estab-
lished (19, 21,23). In addition, purified amine oxidase
and liver lysyl oxidase, the enzyme catalyzing the initial
Steps of collagen and elastin cröss-liiik formation (25),
were found to be antigenically different, and, thus^
• structurally not identical (26). Although resembling the
J. Clin. Chem. Clin. Biochem. / Vol. 20,1982 / No. 7
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type B mitochondrial outer membrane monoamine
oxidase (27—29) several criteria, in particular the sensi-
tivity to the action of lathyrogens (30,31), indicate
clearly marked differences between serum monoamine
oxidase and the tissue type of amine oxidase. Whatever
the functional role and the origin of circulating mono-
amine oxidase, our data confirm on a quantitative basis
the potential but limited diagnostic Utility of this
enzyme. In contrast to some earlier reports (23,24)
significantly elevated activities were found nearly ex-
clusively in fully developed liver cirrhosis but not in
liver fibrosis. Indeed, the frequency distribution of
enzyme activities in sera of patients with liver fibrosis
and non-liver diseases shows no significant differences.
Thus, estimation of monoamine oxidase is not helpful
in the diagnosis of early stages of fibroproliferative liver
dysfunctions, in which fibrostatic therapy might be
successfuL In addition to this observation the U-shaped
frequency distribution of monoamine oxidase activities
in sera of cirrhotic patients (table 1) suggests that
stimulated hepatic connective tissue synthesis and/or
0.2
0.2 0.6 0.8
Prevaletnce pf cirrhosis
1.0
Fig. 4. Predictive values of normal (negative result,^ ) and
pathologically elevated (positive test result, /O mono-
amine oxidase activities äs a function of disease pre-
valence with respect to non-liver cirrhotic patients (cut-
off value of 630 U/l, ; cut-off value of 720 U/l,
increased concentration of intercellular matrix proteins
cari not be the sole (if any) determinant of raised serum
monoamine oxidase activity. Instead, elevated enzyme
activity might indicate a common complication of
advanced fibrotic distortion of the liver parenchyma, i.e.
increased hepatic sinusoidal pressure (portal hyperten-
sion) and portal-systemic collateral circulation (22). In
fact, a striking positive correlation has been found be-
tween serum monoamine oxidase activity and intra-
hepatic venous pressure (22), but not with other,
routinely applied liver function tests (21, 22). If this
assumption is valid the record of enzyme activity could
be valuable in the follow-up of known cirrhosis rather
than in its early diagnosis and, thus, might have prog-
nostic significance. The rather low diagnostic sensitivity,
specificity (fig. 2) and predictive values (figs. 3 and 4)
of abnormally high monoamine oxidase in serum at an
assumed prevalence of cirrhosis of 0.001 or less are in
favour of this view. The criteria might be improved in
more selected populations with greater prevalence of
cirrhosis and/or by consideration of additional diagnostic
Parameters in a multivariate framework. Pathobio-
chemically, the differentiation of the various isoenzymes
of serum monoamine oxidase in liver-cirrhotic subjects
(23, 32, 33) might contribute to an improvement of the
diagnostic validity of the test. Special care has to be
taken on the marked instability of the enzyme in vitro
(16), which otherwise might influence negatively the
diagnostic validity of this parameter. Further studies
have to show whether the estimation of serum mono-
amine oxidase in conjunction with other proposed para-
meters of stimulated hepatic connective tissue metabolism
(13) is adväntageous for an early diagnosis of fibroproli-
ferative liver disorders. This goal, however, will be diffi-
cult to reach at present because of the largely unknown
pathogenesis of liver fibrosis and cirrhosis, the chronicity
pf the process, and the ubiquitous distribution of the
connective tissue elements in the body (34).
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